Therapy Areas: Inflammatory Diseases
18 January 2019 - - US-based commercial-stage biopharmaceutical company Omeros Corp. (NASDAQ: OMER) has finalised its clinical plan for OMS721 submission and approval in immunoglobulin A nephropathy f...
18 January 2019 - - A new paper in Science Translational Medicine showcases the discovery and development of TTP399, an investigational, oral, small molecule, liver-selective glucokinase act...
17 January 2019 - - US-based drug discovery and development company Knopp Biosciences LLC has expanded its research collaboration with Cincinnati Children's Hospital Medical Center to further elu...
17 January 2019 - - US-based emerging specialty pharmaceutical company Aradigm Corp. (OTCQB: ARDM) has received specific, detailed results of an independent third party evaluation of the Phase 3 clini...
17 January 2019 - - US-based immune tolerance company Anokion has named Simon Cooper, MBBS., to the newly created position of chief medical officer, the company said.

Cooper will lead Ano...
17 January 2019 - Biotechnology company Therachon AG said on Wednesday that it has passed the US Food and Drug Administration's (FDA) orphan drug designation for apraglutide for the treatment of ...
Related Headlines